Abstract:This study shows the development of intestinal mucosal injury during ECC with DAP or DAP and SP, indicative of insufficient intestinal perfusion. Intestinal injury was associated with a systemic pro-inflammatory response.
“…Kanda T et al [17] also found that the serum I-FABP level increased in the presence of not only ischemic disease but also other small bowel disease. Hansen et al [18] reported that the blood I-FABP levels rose in patients with small bowel injury associated with extracorporeal circulation and that there was a strong correlation between such small bowel injury and the onset of the systemic inflammatory response syndrome. Guthmann et al [19] reported an elevation of serum I-FABP in children with necrotizing enterocolitis, and Wiercinska-Ddrapalo et al reported a similar elevation in patients with ulcerative colitis [10].…”
“…Kanda T et al [17] also found that the serum I-FABP level increased in the presence of not only ischemic disease but also other small bowel disease. Hansen et al [18] reported that the blood I-FABP levels rose in patients with small bowel injury associated with extracorporeal circulation and that there was a strong correlation between such small bowel injury and the onset of the systemic inflammatory response syndrome. Guthmann et al [19] reported an elevation of serum I-FABP in children with necrotizing enterocolitis, and Wiercinska-Ddrapalo et al reported a similar elevation in patients with ulcerative colitis [10].…”
“…It is also noteworthy that abdominal surgery or decompression with a long tube was required in 47 (72.3%) of our present 65 patients with non-ischemic small bowel disease in whom the serum I-FABP level was above the cutoff level. Recently, Hanssen et al [20] reported that the blood I-FABP level rose in patients with small bowel injury associated with extracorporeal circulation and that there was a strong correlation between such small bowel injury and the onset of the systemic inflammatory response syndrome. These findings suggest that I-FABP is released into the blood by injury of the small bowel epithelium, regardless of the type of injury, and that the elevation of serum I-FABP in non-ischemic diseases may reflect the extent and seriousness of morbidity.…”
Serum I-FABP measurement is a non-invasive method that is potentially useful for the efficient identification of patients with acute abdomen who are at risk of small bowel ischemia.
“…Moreover, IL-6 was the predominant stimulator of most acute-phase proteins [14]. IL-6 concentrations were measured by ELISA as previously described (lower detection limit: 10 pg/mL) [15].…”
Section: Crp Calprotectin and Il-6 Measurementmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.